A Novel Modular Antigen Delivery System for Immuno Targeting of Human 6-sulfo LacNAc-Positive Blood Dendritic Cells (SlanDCs)
2011

A New Way to Deliver Antigens to Dendritic Cells for Vaccination

publication Evidence: moderate

Author Information

Author(s): Bippes Claudia C., Feldmann Anja, Stamova Slava, Cartellieri Marc, Schwarzer Adrian, Wehner Rebekka, Schmitz Marc, Rieber E. Peter, Zhao Senming, Schäkel Knut, Temme Achim, Scofield R. Hal, Kurien Biji T., Bartsch Holger, Bachmann Michael

Primary Institution: Institute of Immunology, Medical Faculty Carl Gustav Carus, Technical University Dresden, Dresden, Germany

Hypothesis

Can a novel modular antigen delivery system effectively target human 6-sulfo LacNAc-positive blood dendritic cells (slanDCs) for vaccination?

Conclusion

The study demonstrates that the slan epitope can be used to deliver antigens to slanDCs, which can then process and present these antigens to T cells.

Supporting Evidence

  • The slan epitope can effectively deliver antigens to slanDCs.
  • Antigens bound to the slan epitope are processed and presented to T cells.
  • The novel modular scaffold system may aid in developing human vaccines.

Takeaway

Scientists created a new system to help deliver vaccines to special immune cells called dendritic cells, which can help the body fight diseases.

Methodology

The study involved developing a multivalent anti-slanDC scaffold for antigen delivery and testing its binding and processing capabilities in vitro.

Limitations

The study primarily focused on in vitro experiments, and the clinical applicability of the findings remains to be established.

Digital Object Identifier (DOI)

10.1371/journal.pone.0016315

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication